Ipecac toxicity in "Munchausen syndrome by proxy"

Citation
Aa. Bader et B. Kerzner, Ipecac toxicity in "Munchausen syndrome by proxy", THER DRUG M, 21(2), 1999, pp. 259-260
Citations number
12
Categorie Soggetti
Pharmacology,"Pharmacology & Toxicology
Journal title
THERAPEUTIC DRUG MONITORING
ISSN journal
01634356 → ACNP
Volume
21
Issue
2
Year of publication
1999
Pages
259 - 260
Database
ISI
SICI code
0163-4356(199904)21:2<259:ITI"SB>2.0.ZU;2-C
Abstract
The authors report a case that offers insight into the diagnostic challenge s of "Munchausen Syndrome by Proxy." Initial presentation with history of f ever and later with intractable vomiting led to invasive and expensive diag nostic evaluation before confirming the diagnosis. Certain toxic effects of emetine were clinically noted. Biochemical and clinical improvement were c learly demonstrated after withdrawal of the toxic agent.